Harrisburg, NC -- (SBWIRE) -- 03/20/2019 -- The Lab-on-a-chip and Microarrays (Biochip) Market report is a collection of pragmatic information, quantitative and qualitative estimation by industry experts, the contribution from industry connoisseurs and industry accomplices across the value chain. Lab-on-a-chip and Microarrays (Biochip) Market Detail Analysis focusing on Key Players like Abbott Laboratories, Affymetrix Inc., Agilent Technologies, Beckman Coulter Inc., Bio-Rad Laboratories Inc., Life Technologies Corp, PerkinElmer and Other Furthermore, the report also provides the qualitative results of diverse market factors on its geographies and segments.
The North America lab-on-a-chip and microarrays (biochip) market is expected to register a CAGR of 29% during the forecast period of 2018-2023. A biochip is a collection of miniaturized test sites (microarrays) arranged on a solid substrate that permits many tests to be performed at the same time, to achieve higher throughput and speed. Typically, a biochip's surface area is no larger than a fingernail. Like a computer chip, that can perform millions of mathematical operations in one-second, a biochip can perform thousands of biological reactions, such as decoding genes, in a few seconds.
Get free sample copy of this report before purchase at:
https://www.marketinsightsreports.com/reports/01241064990/north-america-lab-on-a-chip-and-microarrays-biochip-market-segmented-by-product-application-technology-and-geography-growth-trends-and-forecast-2018-2023/inquiry?source=releasewire&Mode=12
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
North America Lab-on-a-chip and Microarrays (Biochip) Market Report from Market Insights Reports covers market characteristics, size and growth, segmentation, regional breakdowns, competitive landscape, market shares, trends and strategies for this market. The market characteristics section of the report defines and explains the market. The market size section gives the market revenues, covering both the historic growth of the market and forecasting the future. Drivers and restraints look at the external factors influencing the growth of the market. Market segmentations break down the key sub sectors which make up the market.
The United States biochip market held the largest market share in 2017 in North America due to the presence of high-quality healthcare system. The biochip market has recently started in the emerging nations, wherein major investments are expected to happen.
Biochips are being increasingly used in the area of biomedical and biotechnological research. With the advancement of technology in the medical field, there has been a rise in adoption of biochips in proteomics, such as in microarrays. The advantages of protein biochips include low sample consumption and its inclination towards miniaturization. For instance, protein microarrays can display multiple proteins simultaneously, and these characteristics translate into its ability to process thousands of samples parallelly. This characteristic of microarrays is important for proteome-wide analysis. Proteomics is being widely adopted for biomarker discovery and drug discovery. Moreover, the rise in demand for personalized medicine for diseases is contributing to the growth of the market. The other factors, such as increasing use of biochips in cancer treatment and diagnostics, demand for personalized medicine, and rapid technological advances in biochip technology are driving the lab-on-a-chip and microarrays (biochip) market.
Get full access to this report at:
https://www.marketinsightsreports.com/reports/01241064990/north-america-lab-on-a-chip-and-microarrays-biochip-market-segmented-by-product-application-technology-and-geography-growth-trends-and-forecast-2018-2023?source=releasewire&Mode=12
Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in the last five years are identified.The trends and strategies section highlights the likely future developments in the market and suggests approaches.
Following are major Table of Content of Lab-on-a-chip and Microarrays (Biochip) Industry:
- Lab-on-a-chip and Microarrays (Biochip) Market Sales Overview.
- Lab-on-a-chip and Microarrays (Biochip) Market Sales Competition by Manufacturers.
- Lab-on-a-chip and Microarrays (Biochip) Market Sales Analysis by Region.
- Lab-on-a-chip and Microarrays (Biochip) Market Sales Analysis by Type.
- Lab-on-a-chip and Microarrays (Biochip) Market Analysis by Application.
- Lab-on-a-chip and Microarrays (Biochip) Market -Manufacturers Analysis.
The research includes historic data from 2014 to 2018 and forecasts until 2023 which makes the reports an invaluable resource for industry executives, marketing, sales and product managers, consultants, analysts, and other people looking for key industry data in readily accessible documents with clearly presented tables and graphs.
Avail a Good Discount at:
https://www.marketinsightsreports.com/reports/01241064990/north-america-lab-on-a-chip-and-microarrays-biochip-market-segmented-by-product-application-technology-and-geography-growth-trends-and-forecast-2018-2023/discount?source=releasewire&Mode=12
Key Developments in the Market
June 2017: Biochips for wound healing - Complex biology and chip technology have been combined at the Vienna University of Technology. This enables customized, personalized medicine on the smallest spaces. For the first time, a chip for wound healing measurement was introduced publicly at an international expert audience in the exhibition Labvolution.
Contact US:
Irfan Tamboli (Head of Sales)
Market Insights Reports
Phone: + 1704 266 3234 | Mob: +91-750-707-8687
sales@marketinsightsreports.com | irfan@marketinsightsreports.com